HILLEVAX INC (HLVX) Stock Income Statement
NASDAQ:HLVX - Nasdaq - US43157M1027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 79.51M | 107.00M | 133.00M | 65.11M | 53.43M | |||
| Research and Development | 54.18M | 78.17M | 106.68M | 48.41M | 47.67M | |||
| Selling, General, and Administrative Expenses | 25.92M | 29.00M | 27.00M | 16.71M | 5.76M | |||
| Operating Income | -79.51M | -107.00M | -133.00M | -65.11M | -53.43M | |||
| Interest Income/Expense | 4.69M | 5.59M | 7.31M | 460.00K | -2.84M | |||
| Other Income/Expense | 3.77M | 4.29M | 2.47M | -95.16M | -46.14M | |||
| Non Recurring Items | -35.09M | -50.00M | 0.00 | N/A | N/A | |||
| Income Before Taxes | -107.06M | -147.00M | -124.00M | -159.81M | -102.41M | |||
| Net Income | -107.06M | -147.00M | -124.00M | -159.81M | -102.41M | |||
| EBITDA | -76.53M | -103.80M | -130.84M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.15 | -3.00 | -3.04 | -5.89 | -3.23 | |||
| Non GAAP EPS | -2.15 | -3.00 | -3.04 | -13.10 | N/A | |||
| Statistics | ||||||||
All data in USD